Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition On February 26, 2026, Vera Therapeutics, Inc. (the “Company”) issued a press release announcing its financial resu
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Vera Therapeutics, Inc., dated February 26, 2026 . 104 Cover Page